英国单手神经瘤学家和小型中心面临的挑战:以采访为基础的研究提出了解决方案
M Brothwell1, A Wright2, N Huskens2
1Department of Oncology, University College London Hospitals, 235 Euston Road, London NW1 2BU, United Kingdom.
概括
单独的神经瘤实践带来了挑战,对临床医生的福祉和获得研究机会产生了负面影响. 增加国家支持对于这些较小的中心至关重要.
科学领域:
- 癌症学
- 神经科学
- 医疗管理
背景情况:
- 一个人的瘤实践缺乏对其经验和影响的量化证据.
- 了解单独执业者所面临的挑战对于改善医疗服务至关重要.
- 泰莎·乔威尔 (Tessa Jowell) 的脑癌研究团开始研究这种做法.
研究的目的:
- 调查单手神经瘤学家的工作量,挑战和支持网络.
- 为了比较单手医生的经验与大神经瘤中心的经验.
- 确定个人实践对福祉和参与研究的影响.
主要方法:
- 在2024年1月至5月期间进行了半结构化的虚拟采访.
- 来自英国的35名神经瘤学家参与了这项研究.
- 这些中心分为单手 (1位神经瘤学家),双手 (2) 或多手 (3+).
主要成果:
- 单手神经瘤学家报告了同行评审和离职的困难.
- 每十个单独练习者中就有七个对他们的健康有负面影响.
- 较小的中心对多学科服务的获取不公平, 开放的临床试验也较少.
结论:
- 单独的神经瘤实践可能会对临床医生的福祉,招聘和留守产生不利影响.
- 需要加强单手和双手中心的国家支持和研究准入.
- 解决这些差异对于整个英国的神经瘤护理至关重要.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


